| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |